OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report
Peter Malfertheiner, Françis Mégraud, Theodore Rokkas, et al.
Gut (2022) Vol. 71, Iss. 9, pp. 1724-1762
Open Access | Times Cited: 741

Showing 1-25 of 741 citing articles:

Helicobacter pylori infection
Peter Malfertheiner, M. Constanza Camargo, Emad El‐Omar, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 578

Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022
Yi‐Chu Chen, Peter Malfertheiner, Hao-Ting Yu, et al.
Gastroenterology (2024) Vol. 166, Iss. 4, pp. 605-619
Closed Access | Times Cited: 93

2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment
Liya Zhou, Hong Lü, Zhiqiang Song, et al.
Chinese Medical Journal (2022)
Open Access | Times Cited: 92

Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges
Ayman Elbehiry, Eman Marzouk, Musaad Aldubaib, et al.
Antibiotics (2023) Vol. 12, Iss. 2, pp. 191-191
Open Access | Times Cited: 79

World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics
Francisco Guarner, Mary Ellen Sanders, Hania Szajewska, et al.
Journal of Clinical Gastroenterology (2024) Vol. 58, Iss. 6, pp. 533-553
Open Access | Times Cited: 65

Evolving Concepts in Helicobacter pylori Management
Steven F. Moss, Shailja C. Shah, Mimi C. Tan, et al.
Gastroenterology (2023) Vol. 166, Iss. 2, pp. 267-283
Open Access | Times Cited: 40

Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis
Tzu‐Chan Hong, Emad El‐Omar, Yu‐Ting Kuo, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 9, Iss. 1, pp. 56-67
Closed Access | Times Cited: 38

Helicobacter pylori: A Contemporary Perspective on Pathogenesis, Diagnosis and Treatment Strategies
Asghar Ali, Khalid I. AlHussaini
Microorganisms (2024) Vol. 12, Iss. 1, pp. 222-222
Open Access | Times Cited: 36

Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases
Oana-Alina Petrariu, Ilda Czobor Barbu, Adelina-Gabriela Niculescu, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 33

RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates
Massimo Rugge, Robert M. Genta, Peter Malfertheiner, et al.
Gut (2024), pp. gutjnl-331164
Open Access | Times Cited: 30

An antibiotic-free platform for eliminating persistent Helicobacter pylori infection without disrupting gut microbiota
Yongkang Lai, Tinglin Zhang, Xiaojing Yin, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3184-3204
Open Access | Times Cited: 27

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
William D. Chey, Colin W. Howden, Steven F. Moss, et al.
The American Journal of Gastroenterology (2024) Vol. 119, Iss. 9, pp. 1730-1753
Closed Access | Times Cited: 27

Effects of Helicobacter pylori infection on intestinal microbiota, immunity and colorectal cancer risk
Veronika Engelsberger, Markus Gerhard, Raquel Mejías‐Luque
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 24

Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance
Luís Bujanda, Olga P. Nyssen, June Ramos, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 12

Management of Helicobacter pylori infection
Natsuda Aumpan, Varocha Mahachai, Ratha‐Korn Vilaichone
JGH Open (2022) Vol. 7, Iss. 1, pp. 3-15
Open Access | Times Cited: 44

Helicobacter pylori infection: a dynamic process from diagnosis to treatment
Qifang Sun, Chengzhi Yuan, Sainan Zhou, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 35

Hericium erinaceus, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases
Antonietta Gerarda Gravina, Raffaele Pellegrino, Salvatore Auletta, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 20, pp. 3048-3065
Open Access | Times Cited: 31

A Global Perspective on Gastric Cancer Screening: Which Concepts Are Feasible, and When?
Władysław Januszewicz, Maryla H. Turkot, Peter Malfertheiner, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 664-664
Open Access | Times Cited: 24

Helicobacter pylori Antibiotic Resistance: Molecular Basis and Diagnostic Methods
Irina Medakina, Larisa Tsapkova, Vera Polyakova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9433-9433
Open Access | Times Cited: 24

The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy
Meiqi Wang, Ge Yang, Yuan Tian, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24

Drug Resistance Patterns of Commonly Used Antibiotics for the Treatment of Helicobacter pylori Infection among South Asian Countries: A Systematic Review and Meta-Analysis
Abhigan Babu Shrestha, Pashupati Pokharel, Unnat Hamal Sapkota, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 3, pp. 172-172
Open Access | Times Cited: 22

Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled study
Xiang Peng, Huangwei Chen, Yu Wan, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 4011-4019
Open Access | Times Cited: 21

Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double‐blind, placebo‐controlled trial
Nur Izreena Ismail, Khairul Najmi Muhammad Nawawi, Deborah Chew Chia Hsin, et al.
Helicobacter (2023) Vol. 28, Iss. 6
Open Access | Times Cited: 20

Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis
Joseph Edwin Kanu, Jonathan Soldera
World Journal of Gastroenterology (2024) Vol. 30, Iss. 9, pp. 1213-1223
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top